Rx (Prescription Medicine)
USD $ 130.00
Tunib 50mg Capsule 是一种用于治疗特定类型癌症的靶向治疗药物。其活性成分为 Tivozanib，这是一种强效的酪氨酸激酶抑制剂。Tivozanib 通过阻断特定酶的活性，这些酶对于癌细胞的生长和增殖至关重要，尤其是参与肿瘤新血管形成（血管生成）的酶。通过抑制这些通路，Tunib 有助于减缓或停止癌症的进展。
Tunib 50mg Capsule 主要用于治疗已服用两种或以上系统治疗后出现复发或耐药的成年患者的转移性肾细胞癌（RCC）。需要注意的是，本药物只能在合格医疗专业人员的指导下使用。
Tunib 50mg Capsule 的典型剂量和用法将由您的医生根据您的个体情况和治疗反应确定。通常为口服给药。常见不良反应可能包括疲劳、腹泻、高血压、食欲下降、恶心、口腔黏膜炎和体重减轻。严重不良反应可能发生，如出现不寻常的症状，请立即向医生报告。
请将 Tunib 50mg Capsules 存放于室温，避免潮湿和直接光照。并置于儿童不易触及的地方。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Sunitinib 50 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
